Mechanisms of uterine vascular adaptation in pregnancy

妊娠期子宫血管适应机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): Normal pregnancy is characterized by a remarkable enhancement of uterine blood flow due to vasodilation and growth and remodeling of uterine vasculature that is associated with an increased uterine reactivity to vasoconstrictors. The long-term goal of this proposal is to understand the causes and cellular mechanisms underlying the modulation of uterine vascular contractility during gestation, with a specific focus on the role of ion channels in endothelial and vascular smooth muscle cells. Our central hypothesis is that pregnancy down- regulates the delayed rectifier and Ca2+-activated potassium channels with a resultant increase in Ca 2+ influx and smooth muscle contractility. Enhanced Ca 2+ sensitization of contractile process is a synergistical mechanism. Pregnancy-induced up-regulation of PKC and RhoA is proposed as a common regulatory mechanism for enhanced Ca 2+ sensitization and inhibition of K+ channel function. These adaptive changes are counteracted by increased Ca2+-dependent production of endothelium-derived NO and EDHF. Furthermore, we suggest that the effects of pregnancy are highly localized by the side of placentation and are mediated by estrogen. Specific Aim 1 will determine the mechanisms that regulate a steady state global [Ca2+]_ in smooth muscle of uterine resistance arteries, and their modulation in pregnancy. The role of PKC and RhoA in regulation of Ca 2+ sensitization and ion channel function will be studied. Specific Aim 2 will explore the mechanisms by which NO and EDHF mediates the effects of pregnancy on uterine arterial contractility with a specific focus on the role of endothelial intracellular Ca 2+ and small conductance Ca 2+-activated potassium channels. Specific Aim 3 will test the role of local vs. systemic factors, and of estrogen in mediating the effects of pregnancy on uterine artery function. The three Specific aims will integrate the physiological function (regulation of arterial diameter) with intracellular (Ca 2+ signaling, Ca 2+ sensitivity and ion channel function) and molecular (PKC and RhoA) mechanisms and will be accomplished by direct measurements of arterial diameter, intracellular Ca, membrane potential, expression and distribution of PKC and RhoA, and ion currents in endothelial and smooth muscle cells. The proposed study will provide new insights into cellular and molecular mechanisms mediating the effects of pregnancy and estrogen on uterine blood flow and significantly deepen the understanding how these mechanisms are altered in pregnancy-induced hypertension and preeclampsia.
描述(由申请人提供):正常妊娠的特征是由于血管舒张,生长以及子宫脉管结构的生长以及重塑与子宫对血管收缩剂的反应增加有关。该提案的长期目标是了解妊娠过程中子宫血管收缩性调节的原因和细胞机制,并特别关注离子通道在内皮和血管平滑肌细胞中的作用。我们的中心假设是,怀孕降低了延迟的整流器和Ca2+激活的钾通道,导致Ca 2+膨胀和平滑肌收缩性的增加。增强收缩过程的Ca 2+敏化是一种协同机制。妊娠引起的PKC和RHOA的上调被提出是增强Ca 2+敏化和K+通道功能抑制的常见调节机制。这些适应性变化被CA2+依赖性的NO和EDHF的产生增加而抵消。 此外,我们建议妊娠的作用在胎盘侧高度局部,并由雌激素介​​导。具体目标1将确定在子宫抗动脉平滑肌中调节稳态全球[Ca2+] _的机制,并在怀孕中调节。 PKC和RHOA在调节Ca 2+敏化和离子通道功能中的作用将被研究。具体目标2将探讨NO和EDHF介导妊娠对子宫动脉收缩力的影响的机制,并特别关注内皮细胞内Ca 2+的作用,而小型电导Ca 2+激活的钾通道。具体目标3将测试局部因素与系统因素的作用,以及雌激素在介导妊娠对子宫动脉功能的影响中的作用。这三个特定目的将与细胞内(Ca 2+信号传导,Ca 2+敏感性和离子通道功能)和分子(PKC和RhoA)机制相结合的生理功能(动脉直径调节),并将通过直接测量动脉直径,细胞内CA,膜内,膜型和RhoA的表达和RHOA,以及PKC的表达和RHOA,以及直接测量PKC和RHOA,以及PKC的表达和RHOA的分布,肌肉细胞。拟议的研究将为介导妊娠和雌激素对子宫血流的影响的细胞和分子机制提供新的见解,并显着加深理解这些机制在怀孕引起的高血压和前启示性启发前的改变。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Local uteroplacental influences are responsible for the induction of uterine artery myogenic tone during rat pregnancy.
Predominance of local over systemic factors in uterine arterial remodeling during pregnancy.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NATALIA I GOKINA其他文献

NATALIA I GOKINA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NATALIA I GOKINA', 18)}}的其他基金

PPARy and Uterine Vascular Dysfunction in Diabetic Pregnancy
PPARy 与糖尿病妊娠期间的子宫血管功能障碍
  • 批准号:
    7678544
  • 财政年份:
    2008
  • 资助金额:
    $ 29.59万
  • 项目类别:
PPARy and Uterine Vascular Dysfunction in Diabetic Pregnancy
PPARy 与糖尿病妊娠期间的子宫血管功能障碍
  • 批准号:
    7906745
  • 财政年份:
    2008
  • 资助金额:
    $ 29.59万
  • 项目类别:
PPARy and Uterine Vascular Dysfunction in Diabetic Pregnancy
PPARy 与糖尿病妊娠期间的子宫血管功能障碍
  • 批准号:
    7527054
  • 财政年份:
    2008
  • 资助金额:
    $ 29.59万
  • 项目类别:
Mechanisms of uterine vascular adaptation in pregnancy
妊娠期子宫血管适应机制
  • 批准号:
    6630121
  • 财政年份:
    2003
  • 资助金额:
    $ 29.59万
  • 项目类别:
Mechanisms of uterine vascular adaptation in pregnancy
妊娠期子宫血管适应机制
  • 批准号:
    6876631
  • 财政年份:
    2003
  • 资助金额:
    $ 29.59万
  • 项目类别:
Mechanisms of uterine vascular adaptation in pregnancy
妊娠期子宫血管适应机制
  • 批准号:
    6734631
  • 财政年份:
    2003
  • 资助金额:
    $ 29.59万
  • 项目类别:

相似国自然基金

UBR1通过泛素化修饰PTEN调控PI3K/AKT/mTOR促进甲状腺相关眼病血管生成的研究
  • 批准号:
    82360213
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
结合诱导纤维生成肽长效抑制角膜新生血管形成治疗角膜病的机制
  • 批准号:
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
基于Parkin介导HIF-1α泛素化调控血管内皮细胞糖酵解探讨祛湿通脉法抑制RA滑膜血管翳生成的机制研究
  • 批准号:
    82305109
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Nrf1/2调控ACER2介导的SphK-S1P-S1PR通路在肝癌血管生成中的机制研究
  • 批准号:
    82302988
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
微针递送装载VEGF/PDGF-BB基因的腺相关病毒促进烟雾病高龄小鼠颞肌贴敷术后侧支血管生成的研究
  • 批准号:
    82301480
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Pacemakers of Cholinergic Wave Activity in the Developing Retina
视网膜发育中胆碱能波活动的起搏器
  • 批准号:
    10653330
  • 财政年份:
    2023
  • 资助金额:
    $ 29.59万
  • 项目类别:
Investigating the Effects of ADGRB3 Signaling on Incretin-Mediated Insulin Secretion from Pancreatic Beta-Cells
研究 ADGRB3 信号传导对肠促胰素介导的胰腺 β 细胞胰岛素分泌的影响
  • 批准号:
    10666206
  • 财政年份:
    2023
  • 资助金额:
    $ 29.59万
  • 项目类别:
Calcium Channels in Glioblastoma
胶质母细胞瘤中的钙通道
  • 批准号:
    10583656
  • 财政年份:
    2022
  • 资助金额:
    $ 29.59万
  • 项目类别:
Calcium Channels in Glioblastoma
胶质母细胞瘤中的钙通道
  • 批准号:
    10708091
  • 财政年份:
    2022
  • 资助金额:
    $ 29.59万
  • 项目类别:
Targeting peptide Lv and its downstream signaling against ocular neovascularization
靶向肽 Lv 及其下游信号对抗眼部新生血管形成
  • 批准号:
    10210604
  • 财政年份:
    2021
  • 资助金额:
    $ 29.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了